Viral Safety Issues in the Production and Manufacturing of Human Immunoglobulin Preparations from Equine Plasma/Serum

• Published in: Pharmaceutical chemistry journal Vol. 56; no. 4; pp. 532 - 537
• Main Authors: Mashin, V. V., Sergeev, A. N., Martynova, N. N., Sergeev, A. A., Lys’ko, K. A., Raikov, A. O., Kataeva, V. V., Zagidullin, N. V.
• Format: Journal Article
• Language: English
• Published: New York Springer US 01-07-2022; Springer
• Subjects: Drugs; Immunoglobulins; Medicine; Organic Chemistry; Pharmacology/Toxicology; Pharmacy; Safety and security measures; horse; distribution area; viral infection; equine immunoglobulin; virus concentration
• ISSN: 0091-150X; 1573-9031
• DOI: 10.1007/s11094-022-02675-2

The current Russian and foreign pharmacopoeias either do not provide any information about existing types of viral diseases in horses or do not present it in full. Data of modern domestic and foreign literature was used to prepare the most complete list of viruses that cause equine diseases including 36 infectious agents, 25 of which are pathogenic for humans, 13 of the 25 of which are widespread throughout Russia. Information is provided on the magnitudes of the disease incubation periods (which are most often within one month), the external clinical signs of these diseases (which can also be asymptomatic), and the maximum possible concentrations of viruses in the blood of horses with these diseases (which can reach 8 log conventional units/mL of blood). This information is offered for use in critical production stages of heterologous immunoglobulin drugs for medical use to assure viral safety.